Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2013


Controlled Release

18 Mar 2013 - 19 Mar 2013 - London, UK



Bookmark and Share


SMi presents its 10th annual conference on . . .

Controlled Release – the only conference in Europe to focus specifically on controlled release.

At this well-established annual event you will hear, from the global expert speaking faculty, how controlled release products and drugs have developed over the past 12 months.  

ATTEND TO:

• Discover the very latest developments in this innovative and booming industry

• New for 2013:

- Investigating structure-activity relationships of siRNA nanoparticles

- Challenges of pre-clinical gastro-retentive dosage form development

- Numerous case studies from big pharma laboratories – such as GSKs formulation development programme

• Benefit from an interactive half-day post-conference workshop on SMART formulation design: tools and strategies for complex formulation design and problem solving

KEY SPEAKERS INCLUDE:

Michael Keller, PDU Parenteral, Topical & siRNA Lead, Novartis

Andy Lewis, Director, Ipsen

Petra Wicklandt, CMC Development, Merck

Howard Stevens, Professor, Exploratory Drug Discovery, University of Strathclyde

David Elder, Externalisation Director, GlaxoSmithKline

Monica Rosa, Director, SigmoidPharma

Navnit Shah, Distinguished Scientist, Roche

Mark Wilson, Director, Collaboration Management, GlaxoSmithKline

Dmitry Samarsky, Technology & Business Development, Ribobio

Richard Elkes, Senior Research Scientist, Merck 

and many more . . .

Click here for the programme, full speaker line-up and to register http://www.smi-online.co.uk/goto/controlledrelease27.asp 



Further information
Scientific News
Making It Personal
Cancer vaccine linked to increased immune response against leukemia cells.
Gene Therapy Maintains Clotting Factor for Hemophilia Patients
Following a single gene therapy dose, the highest levels of an essential blood clotting factor IX were observed in hemophilia B patients.
BioCision Forms MedCision
The new company will focus on technologies for the management and automation of vital clinical processes.
First New HIV Vaccine Study for Seven Years Begins
South Africa hosts historic clinical trial of experimental HIV vaccine aiming to safely prevent HIV infection.
Study to Assess Shorter-Duration Antibiotics in Children
Physicians plan a clinical trial to evaluate whether short course anti-biotics are effective at treating CAP in children.
Cancer Gene Predicts Treatment Response in Leukaemia
Study indicates the patients suffering from a lethal for of acute myeloid leukemia may live longer when receiving milder chemotherapy drugs.
Injectable Biologic Therapy Reduces Triglycerides
Study finds first-of-its-kind therapy promising for patients with high triglycerides, cholesterol.
Testing Zika Vaccine in Humans Begins
The first of five planned clinical trials to test ZPIV vaccine in humans has begun.
Combination Therapy Improved Chemoresistance in Ovarian Cancer
The study demonstrates how an existing class of targeted therapies could be used to potentiate the tumor suppression induced by cisplatin.
Gene Therapy for Blistering Skin Disease Shows Promise
Grafting genetically altered skin onto patients’ chronic wounds marks the first time skin-based gene therapy has been demonstrated to be safe and effective in humans.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!